Cytek Biosciences (NASDAQ:CTKB) 报告其季度每股收益为0.07美元，高出分析师普遍预期的0.05美元40%。与去年同期的每股收益0.04美元相比增长了75%。公司报告季度销售额为5704.8万美元，低于分析师普遍预期的5938万美元3.21%。与去年同期的销售额5823万美元相比，减少了1.30%。

以上内容来自Benzinga Earnings专栏，原文如下：

Cytek Biosciences (NASDAQ:CTKB) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 percent. This is a 75 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $57.48 million which missed the analyst consensus estimate of $59.38 million by 3.21 percent. This is a 1.30 percent decrease over sales of $58.23 million the same period last year.